Corrigendum: Metastatic extramammary Paget's disease: Pathogenesis and novel therapeutic approach [Front Oncol, 8, (2018), (38)] doi: 10.3389/fonc.2018.00038

Keitaro Fukuda; Takeru Funakoshi

doi:10.3389/fonc.2018.00047

Corrigendum: Metastatic extramammary Paget's disease: Pathogenesis and novel therapeutic approach [Front Oncol, 8, (2018), (38)] doi: 10.3389/fonc.2018.00038

Keitaro Fukuda, Takeru Funakoshi

Department of Dermatology

Research output: Contribution to journal › Comment/debate › peer-review

1 Citation (Scopus)

Abstract

In the published article, there was an error in the number of ongoing clinical trial for HER2-positive unresectable or metastatic EMPD "(UMIN-000006629)". Instead of "(UMIN-000006629)", it should be "(UMIN000021311)". The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Original language	English
Article number	47
Journal	Frontiers in Oncology
Volume	8
Issue number	MAR
DOIs	https://doi.org/10.3389/fonc.2018.00047
Publication status	Published - 2018 Mar 12

Keywords

Anti-PD-1 antibody
CD163+M2 macrophage
CXCR4-stromal cell-derived factor-1 axis
HER2-PI3K/ERK signaling
Lymphangiogenesis
Metastatic extramammary Paget's disease
Mismatch-repair deficient
Receptor activator of nuclear factor kappa-B ligand-RANK signaling

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fonc.2018.00047

Cite this

@article{acbdfbc798bb4192a36d3ed2b4d46696,

title = "Corrigendum: Metastatic extramammary Paget's disease: Pathogenesis and novel therapeutic approach [Front Oncol, 8, (2018), (38)] doi: 10.3389/fonc.2018.00038",

abstract = "In the published article, there was an error in the number of ongoing clinical trial for HER2-positive unresectable or metastatic EMPD {"}(UMIN-000006629){"}. Instead of {"}(UMIN-000006629){"}, it should be {"}(UMIN000021311){"}. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.",

keywords = "Anti-PD-1 antibody, CD163+M2 macrophage, CXCR4-stromal cell-derived factor-1 axis, HER2-PI3K/ERK signaling, Lymphangiogenesis, Metastatic extramammary Paget's disease, Mismatch-repair deficient, Receptor activator of nuclear factor kappa-B ligand-RANK signaling",

author = "Keitaro Fukuda and Takeru Funakoshi",

note = "Publisher Copyright: {\textcopyright} 2018 Fukuda and Funakoshi.",

year = "2018",

month = mar,

day = "12",

doi = "10.3389/fonc.2018.00047",

language = "English",

volume = "8",

journal = "Frontiers in Oncology",

issn = "2234-943X",

publisher = "Frontiers Media S. A.",

number = "MAR",

}

TY - JOUR

T1 - Corrigendum

T2 - Metastatic extramammary Paget's disease: Pathogenesis and novel therapeutic approach [Front Oncol, 8, (2018), (38)] doi: 10.3389/fonc.2018.00038

AU - Fukuda, Keitaro

AU - Funakoshi, Takeru

PY - 2018/3/12

Y1 - 2018/3/12

N2 - In the published article, there was an error in the number of ongoing clinical trial for HER2-positive unresectable or metastatic EMPD "(UMIN-000006629)". Instead of "(UMIN-000006629)", it should be "(UMIN000021311)". The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

AB - In the published article, there was an error in the number of ongoing clinical trial for HER2-positive unresectable or metastatic EMPD "(UMIN-000006629)". Instead of "(UMIN-000006629)", it should be "(UMIN000021311)". The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

KW - Anti-PD-1 antibody

KW - CD163+M2 macrophage

KW - CXCR4-stromal cell-derived factor-1 axis

KW - HER2-PI3K/ERK signaling

KW - Lymphangiogenesis

KW - Metastatic extramammary Paget's disease

KW - Mismatch-repair deficient

KW - Receptor activator of nuclear factor kappa-B ligand-RANK signaling

UR - http://www.scopus.com/inward/record.url?scp=85043518919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043518919&partnerID=8YFLogxK

U2 - 10.3389/fonc.2018.00047

DO - 10.3389/fonc.2018.00047

M3 - Comment/debate

AN - SCOPUS:85043518919

SN - 2234-943X

VL - 8

JO - Frontiers in Oncology

JF - Frontiers in Oncology

IS - MAR

M1 - 47

ER -

Corrigendum: Metastatic extramammary Paget's disease: Pathogenesis and novel therapeutic approach [Front Oncol, 8, (2018), (38)] doi: 10.3389/fonc.2018.00038

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this